Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Abalone Bio
Abalone Bio is a preclinical-stage biotechnology company that develops functionally active antibody drugs targeting challenging disease targets, especially G-protein coupled receptors (GPCRs). Their…
Abalone Bio
Abalone Bio is a preclinical-stage biotechnology company that develops functionally active antibody drugs targeting challenging disease targets, especially G-protein coupled receptors (GPCRs). Their…
TL;DR
Stage: Preclinical / Seed-stage biotechnology
Headquarters: Emeryville, California, United States
Focus: Functionally active antibody therapeutics targeting GPCRs for metabolic, inflammatory disease and cancer
Proprietary tech: Functional Antibody Selection Technology (FAST) platform
Notable investors: Y Combinator; U.S. National Science Foundation
Company Overview
Problem Domain
Discovery of activating antibody therapeutics for metabolic disease, inflammation, and cancer, with emphasis on difficult targets such as GPCRs.
Founded
2017
Industry
Biotechnology
Funding Track Record
230000
NSF grant
1100000
NSF grant
125000
YC participation/seed investment
3000000
Reported $3.0M seed round
Investor Signal
“Y Combinator; U.S. National Science Foundation”
